Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SpringWorks Therapeutics, Inc. | Director | Common Stock | 18.8K | $895K | $47.62 | May 16, 2024 | Direct |
SpringWorks Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.2K | May 16, 2024 | Direct | ||
Solventum Corp | Director | Restricted Stock Units | 5.54K | May 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | May 16, 2024 | 2 | $0 | 4 | May 17, 2024 | Director |
SOLV | Solventum Corp | May 13, 2024 | 2 | $0 | 4 | May 15, 2024 | Director |
SOLV | Solventum Corp | Apr 1, 2024 | 0 | $0 | 3 | Apr 2, 2024 | Director |
SWTX | SpringWorks Therapeutics, Inc. | May 24, 2023 | 2 | $0 | 4 | May 25, 2023 | Director |
SWTX | SpringWorks Therapeutics, Inc. | Jul 14, 2022 | 2 | $0 | 4 | Jul 15, 2022 | Director |
SWTX | SpringWorks Therapeutics, Inc. | Jul 14, 2022 | 0 | $0 | 3 | Jul 15, 2022 | Director |